Analysts reported a decrease in drug purchases for city hospitals

Purchases of medicines by city hospitals decreased in the last half of 2022. Sources and experts interviewed by the newspaper attributed the dynamics to the redistribution of funds due to the fighting in Ukraine,

In the second half of last year, the volume of purchases of drugs for state medical institutions decreased significantly, compared to the same period in 2021, the drop was 32% for district hospitals, 28% for city hospitals and 14% for regional clinics, Kommersant writes with reference to analysts monitoring systems for tender purchases in the pharmaceutical industry Headway Company.

For the entire last year, the drop was 8% year-on-year, to 327.5 billion rubles, 150.2 billion rubles. of which were in the second half of the year. In 2021, the volume of purchases grew by 20% year-on-year to RUB 355.8 billion.

The level of purchases of medicines by medical institutions last year “did not correspond to the previous ten-year period,” said Lyudmila Balandina, HEAD of the strategic development department of Headway Company. In her opinion, the funds reserved for the purchase of drugs could be "directed to the purchase of other groups of medical devices or saved." The interlocutor of the newspaper among distributors confirmed that purchases were reduced in the hospital segment due to a decrease in funding, the funds from which were "reallocated to other costs due to military operations in Ukraine."

Experts named the most expensive medicines purchased at the expense of the budget Society

Such dynamics may be due to the fact that in March, operators were allowed to receive advanced funding at the beginning of the year, said Alexei Fedorov, an expert from the All-Russian Union of Patients. Sergey Shulyak, CEO of DSM Group, agreed with this point of view, pointing out that in the spring hospitals could buy medicines in advance.

This opinion is also confirmed by the data of the Headway Company: according to them, in March last year alone, medical institutions bought drugs for 48.4 billion rubles, which is almost 40% more than in the previous year.

In addition, a decrease in purchases last year correlates with a decline in the incidence of CORONAVIRUS, Shulyak emphasized. According to Headway Company, in 2022, the purchase of antiviral and antimicrobial drugs by state clinics decreased by a quarter, the volume of purchases of two drugs for the treatment of covid-19 decreased the most: olokizumab (by 67% yoy) and levilimab (by 69% yoy) .

Read on RBC Pro Cast a shadow: why illegal Indian business is being legalized Get ready for layoffs: what awaits the labor market in the it sector in 2023 Etsy CEO Josh Silverman: “In the first weeks I fired one in five” “Importzames”:how and with what to replace Western IT systems

WSJ announced the beginning of the "era of expensive drugs" Society

According to the DSM Group, the most expensive drug in RUSSIA purchased through government tenders is the Swiss Luxturna, a gene therapy drug for hereditary retinal dystrophy. The active substance is voretigen neparvovek, the Swiss Novartis sells it outside the United States under an agreement with Spark Therapeutics. The price of one package amounted to 25.99 million rubles, in total, seven pieces were purchased for 181.9 million rubles.